Circulating C-Peptide Levels in Living Children and Young People and Pancreatic β-Cell Loss in Pancreas Donors Across Type 1 Diabetes Disease Duration
Diabetes, ISSN: 1939-327X, Vol: 71, Issue: 7, Page: 1591-1596
2022
- 18Citations
- 18Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations18
- Citation Indexes18
- 18
- CrossRef4
- Captures18
- Readers18
- 18
- Mentions1
- News Mentions1
- News1
Most Recent News
Early Conversion of Intensive Insulin Therapy to IDegLira Demonstrates Higher Efficacy and Safety in Reducing Fasting Blood Glucose and HbA1c in T2DM Patients
Introduction In recent 30 years, the prevalence of diabetes mellitus in China has increased significantly.1,2 The epidemiological survey of diabetes mellitus conducted by the Endocrinology
Article Description
C-peptide declines in type 1 cfabetes, although many long- duration patients retain low, but detectable levels. Histologi- cal analyses confirm that p-cells can remain following type 1 diabetes onset We explored the trends observed in C- peptide decline in the UK Genetic Resource Investigating Diabetes (UK GRID) cohort (N = 4,079), with β-cell loss in pancreas donors from the network for Pancreatic Organ donors with Diabetes (nPOD) biobank and the Exeter Archi- val Diabetes Biobank (EADB) (combined N = 235), stratified by recently reported age at diagnosis endotypes (<7, 7-12, ≥13 years) across increasing diabetes durations. The pro- portion of individuals with detectable C-peptide declined beyond the first year after diagnosis, but this was most marked in the youngest age cyoup (<1-year duration: age <7 years: 18 of 20 [90%], 7-12 years: 107 of 110 [97%], ≥13 years: 58 of 61 [95%] vs. 1-5 years postdiagnosis: <7 years: 172 of 522 [33%], 7-12 years: 604 of 995 [61 %],≥13 years: 225 of 289 [78%]). A similar profile was observed in β-cell loss, with those cfiagnosed at younger ages experiencing more rapid loss of islets containing insulin-positive (insulin+) β-cells<1 year postdiagnosis: age <7 years: 23 of 26 (88%), 7-12 years: 32 of 33 (97%), ≥13 years: 22 of 25 (88%) vs. 1-5 years postdiagnosis: <7 years: 1 of 12 (8.3%), 7-12 years: 7 of 13 (54%), ≥13 years: 7 of 8 (88%). These data should be considered in the planning and interpretation of intervention trials designed to promote β -cell retention and function.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85133102499&origin=inward; http://dx.doi.org/10.2337/db22-0097; http://www.ncbi.nlm.nih.gov/pubmed/35499624; https://diabetesjournals.org/diabetes/article/71/7/1591/146866/Circulating-C-Peptide-Levels-in-Living-Children; https://dx.doi.org/10.2337/db22-0097
American Diabetes Association
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know